Total Funding
65
72
Total FundingSeries B raised
Growth Score 65 in past quarter
-2 pts
Heat Score 72 in past quarter
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
7733
Octant Bio is a developer of synthetic technology used to improve health and treat disease.
- Ling Wong: InvestorPast Role: Anacor Pharmaceutical, Investor
- Sri Kosuri: founder and CEO
About the Company
Octant Bio is a developer of synthetic technology used to improve health and treat disease. Its technology uses synthetic biology, genome engineering, next-generation sequencing, and computational tools to simultaneously measure the activity of thousands of receptor pathways in human cells that enable scientists to apply machine learning methods to
engineer small molecules that interact with multiple receptors and unlock a new potential to treat complex diseases.
South Asian Founded
South Asian Led